Also trades as: 1873.HK (HKSE) · $vol 1M
VBIZF OTC
Viva Biotech Holdings
1W: +0.0%
1M: +0.0%
3M: +42.1%
YTD: -1.1%
1Y: -31.6%
3Y: -4.4%
5Y: -83.2%
$0.19
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$374M
-2.5% ▼
5Y CAGR: +52.1%
Capital Expenditures
$192M
-2.0% ▼
5Y CAGR: +27.8%
Free Cash Flow
$182M
-6.8% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$23M
-124.1% ▼
Net Change in Cash
-$95M
-126.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$387M | $288M | -$528M | -$56M | $296M |
| Depreciation & Amort. | $70M | $153M | $185M | $211M | $214M |
| Stock-Based Comp. | $14M | $21M | $25M | $19M | $4M |
| Change in Working Capital | -$43M | -$168M | -$119M | $31M | -$33M |
| Other Non-Cash Items | $360M | -$363M | $729M | $178M | -$107M |
| Operating Cash Flow | $43M | $78M | $386M | $383M | $374M |
| — Investing Activities — | |||||
| Capital Expenditures | -$593M | -$565M | -$249M | -$188M | -$191M |
| Acquisitions (Net) | -$2.5B | -$211M | -$81M | $4M | $10M |
| Investment Purchases | -$3.8B | -$2.1B | -$233M | -$64M | -$20M |
| Investment Sales | $3.7B | $2.0B | $165M | $117M | $169M |
| Other Investing | -$647M | $29M | $26M | $570M | $217M |
| Investing Cash Flow | -$3.8B | -$869M | -$373M | $439M | $186M |
| — Financing Activities — | |||||
| Net Debt Issuance | $4.5B | -$425M | -$73M | -$825M | -$616M |
| Stock Repurchased | -$66M | -$146M | $0 | -$10M | -$23M |
| Dividends Paid | -$52M | -$16M | $0 | $0 | $0 |
| Other Financing | $952M | -$66M | -$71M | $406M | -$19M |
| Financing Cash Flow | $5.3B | -$653M | -$143M | -$430M | -$658M |
| Net Change in Cash | $1.4B | -$1.5B | -$122M | $358M | -$95M |
| Cash End of Period | $2.3B | $801M | $679M | $1.0B | $942M |
| Free Cash Flow | -$549M | -$487M | $137M | $196M | $182M |